The Glucagon-Like Peptide-1 Receptor Agonist, Semaglutide, for the Treatment of Nonalcoholic Steatohepatitis.

Hepatology

Neuroendocrine Unit, Division of Endocrinology, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA.

Published: October 2021

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8463414PMC
http://dx.doi.org/10.1002/hep.31886DOI Listing

Publication Analysis

Top Keywords

glucagon-like peptide-1
4
peptide-1 receptor
4
receptor agonist
4
agonist semaglutide
4
semaglutide treatment
4
treatment nonalcoholic
4
nonalcoholic steatohepatitis
4
glucagon-like
1
receptor
1
agonist
1

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!